title: [Drug added therapeutic value: what is it, how is it assessed and what should be it's role in pharmaceutical policy?].
authors.affiliation: Departamento de Farmacoepidemiología y Farmacoeconomía, Unidad Médica, Pfizer S.A., Alcobendas, Madrid. javier.soto.alvarez@pfizer.com
authors.forename: J
authors.initials: J
authors.lastname: Soto Alvarez
mesh_terms: D007880:Legislation, Drug; D011050:Policy Making; D013030:Spain